NAFDAC: Nigeria's Food and Drug Regulator Explained
Understand Nigeria’s regulator through its published responsibilities and services, while keeping official directions separate from practical registration preparation.

On this page · 11 sections
- 1What NAFDAC actually is
- 2Product coverage and Nigeria-specific route questions
- 3Published functions, leadership and organisational routing
- 4Regulations, guidance, registration and neighbouring terms
- 5Registration readiness and the official service entry points
- 6A practical record model for registration preparation
- 7Record handoffs and recovery from mismatched information
- 8Three worked cases: scope, record alignment and notices
- 9Public notices, reporting resources and product follow-up
- 10Failure modes and proportionate internal controls
- 11A final internal readiness review
How does NAFDAC (Nigeria) apply to your shop floor?
Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.
01What NAFDAC actually is
NAFDAC is the National Agency for Food and Drug Administration and Control. For manufacturers looking into the Nigeria-specific regulatory context, the useful starting point is to distinguish the agency’s overall role from the particular activity they need to address.
NAFDAC’s official description identifies its public-health role as protecting and promoting public health through an effective and efficient regulatory system. That description concerns food, drugs and other regulated products across manufacture, export, import, advertising, distribution, sale and use—not registration alone.
Its legal basis is stated on the About NAFDAC page: the agency “was established by Decree No. 15 of 1993 as amended by Decree No. 19 of 1999 and now the National Agency for Food and Drug Administration and Control Act Cap N1 Laws of the Federation of Nigeria (LFN) 2004”. The same sentence sets the remit, to regulate and control “the manufacture, importation, exportation, distribution, advertisement, sale and use of Food, Drugs, Cosmetics, Medical Devices, Packaged Water, Chemicals and Detergents (collectively known as regulated products).” That list of activities is wider than registration alone, which is why a manufacturer's NAFDAC readiness work usually touches import, labelling, advertising and post-market questions as well as the dossier.
A practical way to orient a registration enquiry is to ask three questions before assembling documents:
- Which product is involved? Describe the actual product rather than relying on a broad commercial label.
- Which activity needs attention? Identify whether the enquiry concerns manufacture, import, advertising or another activity named in the agency’s description.
- Which official resource addresses that activity? Look for the relevant NAFDAC information rather than treating the agency’s general description as an application instruction.
These questions are an internal orientation method, not an agency-defined classification or legal test. Keep the product, activity and official resource together as the starting context for further review. The broad public-health description should not be used to infer a product-specific document list, fee or processing time.
02Product coverage and Nigeria-specific route questions
NAFDAC’s published functions identify registration of foods, drugs, cosmetics, medical devices, bottled water, chemicals and detergents. This is the agency’s registration-function list, not a product-specific application checklist.
Separately, the website’s “Products We Regulate” navigation uses these groupings: Drugs; Food; Chemicals; Cosmetics; Vaccines, Biologicals, Medical Devices; Veterinary; Narcotics. Keep those menu labels separate from the registration-function categories when mapping a product.
| Jurisdiction | Official product wording | Type of website statement | Route question to resolve |
|---|---|---|---|
| Nigeria | “Undertake the registration of foods, drugs, cosmetics, medical devices bottled water, Chemicals and detergents;” | Published registration function | Which current product-specific directions address this product and its proposed activity? |
| Nigeria | Drugs; Food; Chemicals; Cosmetics; Vaccines, Biologicals, Medical Devices; Veterinary; Narcotics | Product-navigation groupings | Which grouping is a useful starting point, and what directions establish the appropriate route? |
Resolve classification before assigning an internal route
As internal readiness practice, check current product-specific directions for supplements, combination products or unfamiliar formulations before assigning a route. Do not automatically classify a supplement as food or medicine. A navigation label is a starting point for finding information, not a substitute for resolving the product’s classification.
Frame the internal question narrowly: “For this formulation, intended use and proposed Nigerian market activity, which official directions should we follow?” If the answer remains unclear, keep the route provisional and seek clarification rather than treating the nearest menu label as confirmation.
For multi-market teams, maintain a distinct Nigeria-specific NAFDAC route in the product map. This is an organisational control, not an additional agency requirement; neither website list should become a dossier checklist.
03Published functions, leadership and organisational routing
NAFDAC’s published functions extend beyond product registration. Its About page describes these functions; the summary below is an account of the agency’s published role, not a product-specific application checklist.
Three published functions explain why NAFDAC looks behind the paperwork to the product and the site. The agency is to “Conduct appropriate tests and ensure compliance with standard specifications designated and approved by the Council for effective control of quality of regulated products and their raw materials as well as their production processes in factories and other establishments”; to “Undertake appropriate investigation into the production premises and raw materials for regulated products and establish relevant quality assurance systems, including certification of the production sites and of the regulated products”; and to “Undertake inspection of imported regulated products and establish relevant quality assurance systems, including certification of the production sites.” For a foreign manufacturer, the practical reading is that testing of product and raw materials, scrutiny of the production site, and inspection of imported goods are all within the agency's stated role, so batch, raw-material and site-quality records should be retrievable on request rather than assembled only when asked. The homepage also lists Foreign GMP Inspections and Ports Inspection among its service areas, consistent with those functions.
Standards, exports, laboratories and advertising
The agency’s specifications and guidance function covers compiling standard specifications, regulations and guidelines for production, importation, exportation, sales, distribution and registration of regulated products. Its separately listed export function concerns controlling exportation and issuing quality certification for products intended for export—not the registration function covered above.
Two related laboratory and assessment functions address infrastructure and judgement: establishing and maintaining relevant laboratories or other institutions in strategic areas of Nigeria as necessary for its functions, and pronouncing on product quality and safety after appropriate analysis.
For advertising, the published advertisement function is to issue guidelines, grant approvals and monitor advertisements for food, drugs, cosmetics, medical devices, bottled water, chemicals and detergents. Keep advertising questions separate from registration questions rather than treating registration as an advertising decision.
Controlled substances, collaboration and routing
The controlled-substance functions include measures to limit narcotic drugs and psychotropic substances to medical and scientific purposes, plus authorisation for importing and exporting those substances and other controlled substances. These are distinct statements of scope: the import/export function expressly includes other controlled substances.
Additional advisory and information functions include advising governments, the private sector and other interested bodies on regulated-product quality, safety and regulatory provisions; compiling and publishing relevant data from agency activities or other sources; and sponsoring national and international conferences considered appropriate.
NAFDAC also describes collaboration with NDLEA and wider liaison: working with the National Drug Law Enforcement Agency to eradicate drug abuse in Nigeria, and liaising with relevant establishments within and outside Nigeria in pursuit of its functions.
The official homepage identifies Prof Moji Adeyeye as Director General. For current directorate remits and routing, consult the agency’s organisational resources, including NAFDAC Organization, Director General, NAFDAC Management and Service Charter. The navigation also includes NAFDAC Strategic Plan and Regulatory Resources.
As internal routing practice, describe the product and the activity in question before choosing a contact; avoid assigning a directorate from a broad function alone. For regional context, see African supplement registration, while keeping Nigerian agency routing specific to NAFDAC.
04Regulations, guidance, registration and neighbouring terms
With the agency and registration distinctions established above, the next task is choosing the right resource. NAFDAC’s industry resources name NAFDAC Regulations and NAFDAC Guidelines separately. The homepage’s For Industries navigation also uses the label “Gazetted NAFDAC Regulations”. Do not infer a particular registration rule or legal effect from that menu label alone.
| Term | Official description or label | Reader question | Interpretation boundary |
|---|---|---|---|
| NAFDAC | National Agency for Food and Drug Administration and Control | Which agency am I dealing with? | The agency discussed above, not an individual legal text. |
| NAFDAC Regulations | Named under For Industry | Which applicable legal text should I consult? | Read the regulation itself; the navigation label does not establish an obligation. |
| NAFDAC Guidelines | Separately named under For Industry | Where should I look for procedural directions? | Check the relevant document’s scope rather than equating its title with a binding provision. |
| Product Registration | Named under Our Services | Which service relates to my registration query? | The service label does not specify a product-specific procedure. |
| NAFDAC Greenbook | Registered Drug Database | Which database is identified for registered drugs? | Do not extend this description to every regulated product category. |
| Mobile Authentication Services | Named under For Consumers | Which consumer resource should I consult? | The label alone establishes no technology, eligibility criteria or programme obligations. |
The homepage’s Our Services and For Consumers navigation provides the service, database and consumer-resource labels used above.
Keep four information categories separate
- Binding provisions: check the current applicable regulation for a legal obligation.
- Official agency information and guidance: check current product-specific directions for procedural details.
- Suggested internal practice: label preparation checks as company controls, not NAFDAC requirements.
- Software support: treat software as a supporting tool, not regulatory authority; approval and release decisions remain with authorised people.
This is a suggested interpretation discipline, not a registration rule. For regional comparison, use the African supplement registration overview as context, then return to the applicable Nigerian text rather than transferring another jurisdiction’s procedure.
05Registration readiness and the official service entry points
NAFDAC’s official service entry points appear under the homepage’s e-Services navigation with these labels: e-Registration, Clinical trial Application, Submit Dossier, NAFDAC e-Clearance, NAFDAC e-License/Permits (LPCO), and NAFDAC Greenbook. Treat these as service labels, not a mandatory sequence to complete for every product.
Before assembling materials, identify the product and intended activity, then select the relevant current official instructions. Record why those directions fit the proposed activity rather than choosing a service solely because its name sounds familiar. Where applicability remains unclear, assign someone to seek clarification before the team builds its preparation plan. Do not turn a previous product’s submission into a universal template.
Suggested internal preparation lifecycle
The following stages are a coordination method for manufacturers, not prescribed NAFDAC review stages, acceptance criteria or processing times. Build the work plan around the selected official directions rather than treating this workflow as a dossier checklist.
- Scope the product: describe the product and intended activity precisely enough to frame the route question.
- Find official directions: retain the relevant page or document reference and note when the team consulted it.
- Build an index: map the materials identified by those directions to their locations and internal owners; keep unresolved questions visible.
- Check alignment: compare the product identity, activity and document versions across the planned materials before marking preparation complete.
- Conduct human readiness review: have named reviewers assess completeness against the selected directions and record outstanding actions.
- Record agency interaction: capture the service used, date, reference and actual communication separately from the internal review result.
- Follow up: assign responsibility for questions and responses, updating the preparation record when information changes.
Keep three statuses separate
Record internal preparation status, service interaction and agency decision in separate fields. Name the people responsible for internal decisions and preserve the basis for each status change; an audit trail review workflow can structure that internal check. A receipt records an interaction, while a completed checklist records internal work. Treat neither as product approval or batch release. Record any agency decision from its actual communication, and leave authorised quality-release decisions with the responsible people.
- Scope the ProductRecord category, intended activity and Nigerian market context.
- Find official directionsIdentify the relevant current product and service instructions.
- Build the indexLink selected records without creating a universal dossier.
- Check record alignmentCompare identifiers, revisions and unresolved questions.
- Review readiness internallyA named reviewer decides whether preparation is complete.
- Record agency interactionKeep service references and correspondence linked to the product.
- Follow up actionsTrack responses, open questions and relevant public notices.
06A practical record model for registration preparation
Use a suggested internal index to connect product context, preparation decisions and correspondence. This is an information-management model, not a NAFDAC submission specification or mandatory dossier list. Its five entities help a manufacturer retrieve the material behind a decision without confusing internal preparation status with an agency response.
| Entity | Suggested fields and purpose |
|---|---|
| Product | Use product_id as the connecting key. Keep product_name, product_category and target_market as product context, separate from any selected service or agency reference. |
| Route Review | Record product_id, the activity being considered, the selected service where relevant, and official_resource_url. Preserve the team's reasoning for using that resource for that activity. |
| Document Reference | Index selected materials using product_id, document_id, revision, review_status and a retrieval location. Include illustrative materials, such as a label or supporting report, only where applicable directions call for them. |
| Agency Interaction | Preserve product_id, the related activity, service name, agency reference where issued, and supporting correspondence. Keep the external reference distinct from the manufacturer's own tracking identifier. |
| Internal Review | Record product_id, the activity reviewed, reviewer, review date and open-action status. Identify the document revisions considered and link any actions to the relevant material or interaction. |
A product may have several activities under review, so product_id alone should not determine where correspondence belongs. Link each message to its actual product and activity; where it concerns several products, identify those relationships explicitly rather than copying it into unrelated records. This applies the separation of identity, context and status discussed in data integrity by design.
Keep Document Reference as an index, not a substitute for the underlying document. When a revision changes, retain which version the reviewer considered. An audit trail can provide the change history for that internal index. The reviewer should record their decision and unresolved actions separately from the wording of any external communication.
Product
Identifies the product and market context.
- product_id
- product_name
- product_category
- target_market
Route Review
Connects the activity to official directions.
- route_review_id
- product_id
- activity
- official_resource_url
Document Reference
Identifies the selected version for review.
- document_id
- product_id
- revision
- review_status
Agency Interaction
Preserves the relevant service and correspondence reference.
- interaction_id
- product_id
- service_name
- agency_reference
Internal Review
Records human ownership and unresolved actions.
- review_id
- product_id
- reviewer_name
- action_status
07Record handoffs and recovery from mismatched information
As an internal coordination practice, map how product master data and controlled document references feed the readiness index. The index should point to originating records rather than become a competing master. This supports data integrity by design and can use manual records or existing tools.
| Information | Originating record | Handoff check | Responsible person |
|---|---|---|---|
| Product identifiers | Product master | Same product and variant | Product data owner |
| Document revisions | Controlled document register | Index points to intended revision | Document controller |
| Service references | Service correspondence | External reference copied accurately | Regulatory coordinator |
| Open actions | Internal action log | Owner and status agree | Action owner |
These rows and roles are illustrative. Keep external service references in separate fields from internal record identifiers; link them without replacing either. Manual reconciliation is an option: compare correspondence with the index and record who checked the match. This approach does not depend on a NAFDAC import format, connector, API or automated synchronisation.
Recovering from a mismatch
- Preserve both conflicting references and their context.
- Identify the originating record for each value.
- Assign an owner to investigate the discrepancy.
- Reconcile the values against the originating records.
- Record the correction, reason, date and responsible person.
- Obtain a fresh internal review where the correction affects an earlier readiness decision.
Use this internal workflow alongside audit trail review; it is not an agency amendment procedure. Check any applicable agency correction instructions separately.
For a service interruption, retain attempted-action details: service used, date and time, intended action, displayed message and any reference received. Route the issue through the appropriate official contact or service instructions. Do not assume that email, post or another channel is an accepted alternative submission method.
08Three worked cases: scope, record alignment and notices
These hypothetical cases illustrate internal preparation, not agency requirements. Each records a bounded result and leaves the next decision with a named human reviewer.
Case 1 — Two products, two scoping rows
Assumptions: A manufacturer is preparing one food product and one cosmetic product for Nigeria. It creates two distinct internal product records.
Reasoning: Keep the scope questions separate. Consult NAFDAC’s official website for current product-specific directions, using the following two rows to organise the enquiries.
| Internal record | Official directions to consult | Question for review |
|---|---|---|
| Food product | NAFDAC directions for food product registration | Which directions apply to this product and its intended supply route? |
| Cosmetic product | NAFDAC directions for cosmetic product registration | Which directions apply to this product and its intended supply route? |
Recorded result: Two internal scoping rows; these do not establish the required number of applications. Next human action: The regulatory lead checks applicability separately and records the official direction used before deciding how to proceed.
Case 2 — Twelve document references
Assumptions: A pharmaceutical team checks 12 document references against its selected internal versions. Nine match; three need reconciliation.
Reasoning: 9 ÷ 12 × 100 = 75% aligned references; 3 ÷ 12 × 100 = 25% unresolved references. The units are document references, and the denominator is this internal sample only.
Recorded result: Nine aligned and three unresolved references, not a compliance score, registration probability or legal acceptance threshold. Next human action: The document owner reconciles the three mismatches, records the decisions and repeats the comparison. An exception-based review can focus attention on those unresolved items without concealing the original sample.
Case 3 — Twenty distribution records
Assumptions: A device distributor compares a hypothetical notice with 20 internal distribution records. Five match the identifiers being assessed; 15 do not match those identifiers.
Reasoning: 5 ÷ 20 × 100 = 25% flagged for closer internal assessment. The units are distribution records, not devices or customers.
Recorded result: Five identifier matches, with the comparison criteria retained. This establishes neither a recall decision nor a safety conclusion for the other 15 records. Next human action: The responsible reviewer checks the notice’s scope, identifier completeness and record accuracy before deciding the next action. Retain the assessment alongside recall-readiness records.
09Public notices, reporting resources and product follow-up
NAFDAC’s consumer resources include “Recalls and Safety Alerts”, “Field Safety Alerts” and “Report Adverse Drug Reactions”. These named resources give manufacturers practical starting points for finding notices and drug-reaction reporting information alongside registration preparation.
The homepage separately names “Report Adverse Events Associated With the use of Medical Devices & IVDs”. Keep that resource distinct when directing a device or IVD question; consult the official reporting resource for instructions. For general terminology, see adverse event reporting.
The homepage’s “Market Authorization Withdrawal” description says the products listed on that page have been officially withdrawn, suspended or cancelled by the Agency, either for commercial reasons or due to deregistration. That description concerns the listed products; it is not a finding about every product in a manufacturer’s portfolio.
Suggested internal follow-up
As an internal practice, assign an owner to assess relevant notices and connect the assessment to affected product records. Keep three elements distinguishable:
- Notice wording: retain the notice title, official link and the wording relevant to the assessment.
- Internal interpretation: record which product records appear affected, the basis for that match and any uncertainty requiring clarification.
- Resulting action: document the decision, responsible person and follow-up, including the rationale if no action is proposed.
This suggested control sets neither a review frequency nor a reporting deadline. Route decisions to authorised people rather than treating a notice match as an automatic disposition.
10Failure modes and proportionate internal controls
NAFDAC’s homepage description of its Blacklist of Companies lists concerns including poor manufacturing practices, submission of falsified documents, quality defects, and breaches of importation or licensing requirements. These are concerns identified in that description—not an exhaustive registration-review checklist.
For manufacturers, the following are suggested internal preparation controls, not prescribed NAFDAC procedures. Scale the review to the issue and record the reasoning in a quality risk register where useful.
| Concern | Suggested internal control | Review output |
|---|---|---|
| Document provenance | Consider checking the issuer, original record and revision before relying on a document. | A checked document origin, with reviewer and supporting reference. |
| Unresolved manufacturing or quality concerns | Consider referring the issue and supporting records to the responsible quality reviewer for assessment. | A recorded quality assessment identifying unresolved questions. |
| Uncertainty about applicable importation or licensing instructions | Consider assigning a regulatory lead to clarify the product and activity against the relevant official instructions. | An assigned regulatory question with a named owner and follow-up action. |
Escalate unresolved issues to named people: the document owner for uncertain provenance, the authorised quality reviewer for manufacturing or defect concerns, and the regulatory lead for instruction questions. Record the person’s name, the decision needed and the next action. Treat an internal status such as “review complete” only as a workflow result—not as NAFDAC approval or an authorised quality decision.
11A final internal readiness review
Use this advisory checklist to close the preparation work described above. It is an internal coordination aid, not a NAFDAC application checklist, approval condition or product-release authorisation.
- Identify the product and intended activity in Nigeria.
- Locate current official directions relevant to that context.
- Assign each outstanding route question to a named person.
- Align selected record references using the record model above.
- Keep service interactions traceable to correspondence and reference numbers.
- Name the internal review owner and clarify their decision scope.
- Make unresolved actions visible, with owners and next steps.
- Consider relevant notices and record their relevance to the product.
Use exception-based review to focus follow-up on remaining discrepancies rather than reopening every aligned record. Carry unresolved questions into the scenario-led FAQs that follow; use the earlier route, record and notice sections for detail.
Frequently asked questions
Q.How should a manufacturer ask about a product that does not fit the website’s categories neatly?+
As general preparation, write a neutral product description covering composition, intended use, presentation, proposed claims and the activity planned in Nigeria. Explain which categories seem plausible and what creates the uncertainty, rather than selecting a category merely to progress an application. Ask NAFDAC which route and responsible office apply to that description. Keep the response attached to the product’s internal regulatory record, and use change control to revisit the question if the description changes materially.
Q.Where should a team start when both e-Registration and e-Clearance appear relevant to an imported product?+
Start with a routing enquiry rather than assuming that either service substitutes for the other. As an internal preparation step, distinguish the product-level question from the particular import transaction: identify the product, intended activity, shipment context and any existing agency references. Ask NAFDAC which service applies to each question and whether an order of action applies. Keep separate enquiry records, linked through an audit trail, without treating a portal submission as the answer to both questions.
Q.How should an advertising question be framed separately from a product-registration question?+
NAFDAC’s About page, advertising function describes issuing guidelines, granting approvals and monitoring advertisements for its listed products. For enquiry preparation, identify the exact advertising wording, artwork version, medium and intended audience; distinguish these from the question about registering the product itself. Ask what applies to that proposed advertisement, without assuming that a product-registration response also addresses promotional wording. A separate label-claim review can help the team identify precisely which statements need clarification.
Q.What information can an exporter organise before asking about quality certification?+
NAFDAC’s About page, export function states that it controls exportation and issues quality certification for products intended for export. As voluntary enquiry preparation—not a prescribed document list—organise the product identity, manufacturer, destination, intended shipment and available quality records. Explain whether the question concerns a product generally or a particular consignment, and ask which certification process applies. Use the relevant batch record to locate existing production information rather than creating unsupported declarations.
Q.How can controlled-substance questions be kept distinct from routine product-registration preparation?+
NAFDAC’s About page, controlled-substance authorisation function identifies authorisation for importing and exporting narcotic drugs, psychotropic substances and other controlled substances. As internal practice, give the substance question its own enquiry: identify the substance, its role in the product, intended use and proposed movement. Ask whether that function applies instead of inferring an answer from ordinary registration preparation. Track the unresolved question in a quality risk register, with an owner responsible for obtaining clarification.
Q.How should a multi-product manufacturer keep Greenbook references distinct from device and cosmetic records?+
As an internal indexing practice, store each Greenbook reference against the exact product identity and description shown in that entry. Maintain separate device and cosmetic records, and do not copy a reference between products because they share a brand, supplier or manufacturer. Record where each reference came from and what it actually says; ask NAFDAC about any uncertain match or scope. This supports data integrity by design without assuming that one reference establishes another product’s status.
Q.What should a team do when a public notice resembles its product but the identifiers are incomplete?+
As a precautionary internal workflow, preserve the notice and compare every stated identifier with stock and distribution records. Separate confirmed matches, possible matches and unresolved differences; resemblance alone should not become a definitive conclusion. Escalate promptly to the responsible quality or regulatory person and ask NAFDAC to clarify the missing identifiers. Record any interim handling decision and its rationale. Keep the comparison within recall readiness procedures so the team can act on clarification without losing traceability.
Primary sources
Want to see how NAFDAC (Nigeria) could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.
